NasdaqCM - Delayed Quote • USD
SAB Biotherapeutics, Inc. (SABS)
At close: June 7 at 4:00 PM EDT
Performance Overview
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is S&P 500
| Return | SABS | S&P 500 |
|---|---|---|
| YTD | -57.22% | +12.10% |
| 1-Year | -69.01% | +24.82% |
| 3-Year | -97.01% | +26.41% |